Press release
Orally Disintegrating Tablet (ODT) Market Analysis, Size, Current Scenario and Future Prospects
For instance, in February 2022, Dr Reddy's Laboratories Ltd. along with its subsidiaries announced the launch of Lansoprazole DR Orally Disintegrating Tablets. These tablets are a therapeutic equivalent generic version of Prevacid SoluTab delayed-release orally disintegrating tablets, 15 mg and 30 mg, which is approved by the US FDA. Additionally, in July 2021, SPI Pharma launched UltraBurst an orally disintegrating tablet (ODT). Ultrabrust is an innovative excipient platform for flash ODTs, which disintegrate in under ten seconds. Furthermore, in December 2021, Edenbridge Pharmaceuticals, LLC announced the approval of its New Drug Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating tablets from the US FDA. DARTISLA ODT is an orally disintegrating tablet available in 1.7 mg for the treatment of peptic ulcers in adults.
Some major players in the market include Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2021, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the US. Rimegepant is commercialized as Nurtec ODT in the US and is used for the treatment of episodic migraine in adults.
To Request a Sample of our Report on Orally Disintegrating Tablet (ODT) Market: https://www.omrglobal.com/request-sample/orally-disintegrating-tablet-odt-market
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2022-2030
• Segment Covered-
· By Drug Class
· By Disease Indication
· By Distribution Channel
• Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape- Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others.
A full Report Orally Disintegrating Tablet (ODT) Market is Available @ https://www.omrglobal.com/industry-reports/orally-disintegrating-tablet-odt-market
Orally Disintegrating Tablet (ODT) Market Report by Segment
By Drug Class
• Anti-Psychotics
• Anti-Epileptics
• CNS Stimulants
• Anxiolytics
• Anti-Parkinsonian Drugs
• NSAIDS
• Anti-Allergy Drugs
• Others
By Disease Indication
• CNS Diseases
• GI Diseases
• CVS Disorders
• Allergy
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
Orally Disintegrating Tablet (ODT) Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orally Disintegrating Tablet (ODT) Market Analysis, Size, Current Scenario and Future Prospects here
News-ID: 3229398 • Views: …
More Releases from Orion Market Research
Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033.
Digital Innovation in Insurance Market Overview
The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are…
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033.
Cigarette Rolling Paper Market Overview
The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers…
Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033.
Back Glue Market Overview
The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive…
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033.
Autopilot Systems Market Overview
The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These…
More Releases for ODT
Phase 3 Clinical Trial for Major Depressive Disorder Treatment Market Begins 202 …
The Global Major Depressive Disorder Market size reached US$ 6.84 billion in 2024 and is expected to reach US$ 14.57 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
The Major Depressive Disorder Market report, released by DataM Intelligence, offers comprehensive insights and thorough analysis of major market trends, growth prospects, and emerging challenges. With a strong focus on actionable intelligence, DataM Intelligence equips businesses with…
Orally Disintegrating Tablet (ODT) Market Share 2021 Growth Challenges, Opportun …
The global orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). According to the US Food and Drug Administration (FDA), ODT’s are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second. The major factor for the growth of the global orally disintegrating tablet (ODT) market during the…
Orally Dissolving Tablets (ODT) Excipient Market global outlook and forecast 202 …
The Global Orally Dissolving Tablets (ODT) Excipient Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Orally Dissolving Tablets (ODT) Excipient makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and…
Investigation announced for Long-Term Investors in shares of Odonate Therapeutic …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Odonate Therapeutics, Inc..
Investors who are current long term investors in Odonate Therapeutics, Inc. (NASDAQ: ODT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ODT stocks follows a lawsuit filed against Odonate…
Deadline on Nov. 16th coming up in Lawsuit for Investors in Odonate Therapeutics …
The Shareholders Foundation announced that a deadline is coming up on November 16, 2020 in the lawsuit filed for certain investors of Odonate Therapeutics, Inc. (NASDAQ: ODT) over alleged securities laws violations by Odonate Therapeutics, Inc.
Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and there are strict and short deadlines running. Deadline: November 16, 2020. NASDAQ: ODT stockholders should contact the Shareholders Foundation at…
Lawsuit filed for Investors in shares of Odonate Therapeutics, Inc. (NASDAQ: ODT …
An investor, who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT), filed a lawsuit over alleged Securities Laws violations by Odonate Therapeutics, Inc.
Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 16, 2020. NASDAQ: ODT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Diego, CA based Odonate Therapeutics,…
